-
Start Preamble
Start Printed Page 45514
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Human Genome Research Institute Special; Emphasis Panel Evans Clinical Trial.
Date: August 3, 2016.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute, 5635 Fisher Lane, 3rd Floor Conference Room, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review Officer, Scientific Review Branch, National Human Genome Research Institute, 5635 Fishers Lane, Suite 4076, MSC 9306, Rockville, MD 20852, (301) 402-0838, pozzattr@mail.nih.gov.
This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS)
Start SignatureDated: July 7, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-16592 Filed 7-13-16; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Effective Date:
- 8/3/2016
- Published:
- 07/14/2016
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2016-16592
- Dates:
- August 3, 2016.
- Pages:
- 45514-45514 (1 pages)
- PDF File:
- 2016-16592.pdf